SPO Medical : Agreement In Sleep Apnea Market

March 9, 2010 - SPO Medical Inc. (SPOM), a leading developer of biosensor and microprocessor technologies for use in portable monitoring devices, announced it has signed a Memorandum of Understanding (MOU) with MetroSleep Inc, a US corporation that specializes in products to diagnose and treat sleep apnea through at-home testing. The MOU enables the integration of SPO Medical’ ASIC chip-set technology in a new MetroSleep product offering for the Sleep Disturbance Breathing (SDB) monitoring market. The terms include an advance licensing fee and a subsequent royalty payment to SPO once the products are commercially available. In addition, MetroSleep will remunerate SPO on a usage-fee basis via SDB devices that are deployed by MetroSleep in the market. The MOU provides that the parties shall enter into legally binding agreements upon MetroSleep receiving required funding for launch of the products... [PDF] SPO Medical's Press Release -

SomnoMed : New Product Line to Treat Sleep Bruxism

19th January 2010 - SomnoMed, the world’s leading dental sleep appliance company, announced the launch of SomnoMed Brux (SomBrux™), an innovative new range of products treating sleep bruxism. Sleep Bruxism (“SB”) is a common sleep-related movement disorder that is characterised by clenching or grinding of the jaws or teeth.
Medical studies indicate a prevalence of approximately 8% in the adult population of western societies and an equal occurrence in men and women. The condition is currently treated with a wide range of products, mostly individually made by dental technicians. Based on company research, the global market is currently in excess of 2 million units per year, representing a wholesale value of around US$ 200 to $300 million, with an annual growth tendency of 8 to 12%.
The new SomnoMed Brux product line will be introduced in Australia in February 2010, followed during the year by launches in all major global markets where SomnoMed is represented. SomBrux™, like the leading SomnoDent® device treating sleep apnea, is custom made and offered in various designs. It is expected that one of its unique selling points is the use of SomnoMed’s SMH BFlex material, which offers unrivalled patient comfort and durability... [PDF] SomnoMed's Press Release -

Fisher & Paykel Healthcare : New CPAP Range

10 March 2010 - Fisher & Paykel Healthcare Corporation Limited (NZSX:FPH, ASX:FPH) announced that it has introduced into Australia and New Zealand its new ICON continuous positive airway pressure (CPAP) devices for the treatment of obstructive sleep apnea (OSA).
The ICON range integrates Fisher & Paykel Healthcare’s leading technologies into stylish, compact and intelligent devices to deliver a better night’s sleep for OSA patients. The F&P ICON also includes a digital clock, alarm and music playing capabilities to enhance patient adaptation to CPAP therapy.
“The ICON combines both exceptional style and technology to fit unobtrusively into the home setting. It has a very small footprint and incorporates our innovative technologies including, SmartStick, ThermoSmart and SensAwake”... [PDF] Fisher & Paykel Healthcare's Press Release -